Search
Moxazocine
go.drugbank.com/drugs/DB20517ExperimentalThe usage of the INN stem '-azocine' in the name indicates that Moxazocine is a narcotic antagonist/agonist related to 6,7-benzomorphan. Moxazocine has a monoisotopic molecular weight of 287.19 Da.
Mespirenone
go.drugbank.com/drugs/DB20625ExperimentalThe usage of the INN stem '-renone' in the name indicates that Mespirenone is a mineralocorticoid receptor (MR, MCR, aldosterone receptor) antagonist.
Propyperone
go.drugbank.com/drugs/DB20765ExperimentalThe usage of the INN stem '-perone' in the name indicates that Propyperone is a tranquillizer, neuroleptic, 4'-fluoro-4-piperidinobutyrophenone derivative.
Carperone
go.drugbank.com/drugs/DB21088ExperimentalThe usage of the INN stem '-perone' in the name indicates that Carperone is a tranquillizer, neuroleptic, 4'-fluoro-4-piperidinobutyrophenone derivative.
Pentamustine
go.drugbank.com/drugs/DB21291ExperimentalThe usage of the INN stem '-mustine' in the name indicates that Pentamustine is a antineoplastic, alkylating agent, (β-chloroethyl) amine derivative.
Izilendustat
go.drugbank.com/drugs/DB21532ExperimentalThe usage of the INN stem '-dustat' in the name indicates that Izilendustat is a hypoxia inducible factor (HIF) prolyl hydroxylase inhibitor.
Civorebrutinib
go.drugbank.com/drugs/DB21641ExperimentalThe usage of the INN stem '-brutinib' in the name indicates that Civorebrutinib is a agammaglobulinaemia tyrosine kinase (Bruton tyrosine kinase) inhibitor.
Pictilisib
go.drugbank.com/drugs/DB11663InvestigationalPictilisib has been used in trials studying the treatment of Solid Cancers, Breast Cancer, Advanced Solid Tumours, Metastatic Breast Cancer, and Non-Hodgkin's Lymphoma, Solid Cancers, among others.
5-fluoro-2'-deoxycytidine
go.drugbank.com/drugs/DB12957Investigational5-fluoro-2'-deoxycytidine has been used in trials studying the treatment of Neoplasms, Lung Neoplasms, Breast Neoplasms, Head and Neck Neoplasms, and Urinary Bladder Neoplasms, among others.
Vatreptacog alfa
go.drugbank.com/drugs/DB12409InvestigationalVatreptacog Alfa (Activated) has been used in trials studying the treatment of Haemophilia B, Haemophilia A, Congenital Bleeding Disorder, Haemophilia A With Inhibitors, and Haemophilia B With Inhibitors